STOCK TITAN

[Form 4] Carter's Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Carter's (NYSE:CRI) director Hali Borenstein filed a Form 4 disclosing the automatic acquisition of 14.8783 common shares on 06/20/2025 at $0.00 per share under the company’s director deferred-compensation program. The dividend-equivalent credit raised her directly held balance to 16,975.0112 shares.

No open-market purchases, sales, or derivative transactions were reported, and the filing contains no other material disclosures or amendments. The transaction appears routine and is not tied to a Rule 10b5-1 trading plan.

Hali Borenstein, membro del consiglio di amministrazione di Carter's (NYSE:CRI), ha presentato un Modulo 4 comunicando l’acquisizione automatica di 14,8783 azioni ordinarie il 20/06/2025 a $0,00 per azione, nell’ambito del programma di compensazione differita per i direttori della società. Il credito equivalente ai dividendi ha portato il suo saldo diretto a 16.975,0112 azioni.

Non sono stati segnalati acquisti o vendite sul mercato aperto, né transazioni derivati, e la comunicazione non contiene altre divulgazioni o modifiche rilevanti. L’operazione sembra di routine e non è collegata a un piano di negoziazione secondo la Regola 10b5-1.

Hali Borenstein, directora de Carter's (NYSE:CRI), presentó un Formulario 4 revelando la adquisición automática de 14.8783 acciones comunes el 20/06/2025 a $0.00 por acción bajo el programa de compensación diferida para directores de la empresa. El crédito equivalente a dividendos elevó su saldo directo a 16,975.0112 acciones.

No se reportaron compras, ventas ni transacciones con derivados en el mercado abierto, y la presentación no contiene otras divulgaciones o enmiendas materiales. La transacción parece rutinaria y no está vinculada a un plan de negociación bajo la Regla 10b5-1.

Carter's (NYSE:CRI) 이사인 Hali Borenstein가 2025년 6월 20일 회사 이사 연기 보상 프로그램에 따라 14.8783주 보통주를 자동 취득했음을 Form 4를 통해 공시했습니다. 주당 가격은 $0.00였습니다. 배당금 상당액이 직접 보유 주식 수를 16,975.0112주로 증가시켰습니다.

공개 시장에서의 매수, 매도 또는 파생상품 거래는 보고되지 않았으며, 제출 서류에는 다른 중요한 공시나 수정 사항이 없습니다. 이번 거래는 일상적인 것으로 보이며 Rule 10b5-1 거래 계획과는 관련이 없습니다.

Hali Borenstein, administratrice de Carter's (NYSE:CRI), a déposé un formulaire 4 révélant l’acquisition automatique de 14,8783 actions ordinaires le 20/06/2025 à 0,00 $ par action dans le cadre du programme de rémunération différée des administrateurs de la société. Le crédit équivalent aux dividendes a porté son solde détenu directement à 16 975,0112 actions.

Aucun achat, vente ou transaction sur dérivés sur le marché ouvert n’a été signalé, et le dépôt ne contient aucune autre divulgation ou modification importante. La transaction semble routinière et n’est pas liée à un plan de négociation selon la règle 10b5-1.

Hali Borenstein, Direktorin von Carter's (NYSE:CRI), reichte ein Formular 4 ein, in dem der automatische Erwerb von 14,8783 Stammaktien am 20.06.2025 zu einem Preis von $0,00 pro Aktie im Rahmen des aufgeschobenen Vergütungsprogramms für Direktoren des Unternehmens offengelegt wurde. Die Dividendenäquivalenzgutschrift erhöhte ihren direkt gehaltenen Bestand auf 16.975,0112 Aktien.

Es wurden keine Käufe, Verkäufe oder Derivatgeschäfte am offenen Markt gemeldet, und die Einreichung enthält keine weiteren wesentlichen Offenlegungen oder Änderungen. Die Transaktion erscheint routinemäßig und ist nicht an einen Handelsplan nach Regel 10b5-1 gebunden.

Positive
  • None.
Negative
  • None.

Hali Borenstein, membro del consiglio di amministrazione di Carter's (NYSE:CRI), ha presentato un Modulo 4 comunicando l’acquisizione automatica di 14,8783 azioni ordinarie il 20/06/2025 a $0,00 per azione, nell’ambito del programma di compensazione differita per i direttori della società. Il credito equivalente ai dividendi ha portato il suo saldo diretto a 16.975,0112 azioni.

Non sono stati segnalati acquisti o vendite sul mercato aperto, né transazioni derivati, e la comunicazione non contiene altre divulgazioni o modifiche rilevanti. L’operazione sembra di routine e non è collegata a un piano di negoziazione secondo la Regola 10b5-1.

Hali Borenstein, directora de Carter's (NYSE:CRI), presentó un Formulario 4 revelando la adquisición automática de 14.8783 acciones comunes el 20/06/2025 a $0.00 por acción bajo el programa de compensación diferida para directores de la empresa. El crédito equivalente a dividendos elevó su saldo directo a 16,975.0112 acciones.

No se reportaron compras, ventas ni transacciones con derivados en el mercado abierto, y la presentación no contiene otras divulgaciones o enmiendas materiales. La transacción parece rutinaria y no está vinculada a un plan de negociación bajo la Regla 10b5-1.

Carter's (NYSE:CRI) 이사인 Hali Borenstein가 2025년 6월 20일 회사 이사 연기 보상 프로그램에 따라 14.8783주 보통주를 자동 취득했음을 Form 4를 통해 공시했습니다. 주당 가격은 $0.00였습니다. 배당금 상당액이 직접 보유 주식 수를 16,975.0112주로 증가시켰습니다.

공개 시장에서의 매수, 매도 또는 파생상품 거래는 보고되지 않았으며, 제출 서류에는 다른 중요한 공시나 수정 사항이 없습니다. 이번 거래는 일상적인 것으로 보이며 Rule 10b5-1 거래 계획과는 관련이 없습니다.

Hali Borenstein, administratrice de Carter's (NYSE:CRI), a déposé un formulaire 4 révélant l’acquisition automatique de 14,8783 actions ordinaires le 20/06/2025 à 0,00 $ par action dans le cadre du programme de rémunération différée des administrateurs de la société. Le crédit équivalent aux dividendes a porté son solde détenu directement à 16 975,0112 actions.

Aucun achat, vente ou transaction sur dérivés sur le marché ouvert n’a été signalé, et le dépôt ne contient aucune autre divulgation ou modification importante. La transaction semble routinière et n’est pas liée à un plan de négociation selon la règle 10b5-1.

Hali Borenstein, Direktorin von Carter's (NYSE:CRI), reichte ein Formular 4 ein, in dem der automatische Erwerb von 14,8783 Stammaktien am 20.06.2025 zu einem Preis von $0,00 pro Aktie im Rahmen des aufgeschobenen Vergütungsprogramms für Direktoren des Unternehmens offengelegt wurde. Die Dividendenäquivalenzgutschrift erhöhte ihren direkt gehaltenen Bestand auf 16.975,0112 Aktien.

Es wurden keine Käufe, Verkäufe oder Derivatgeschäfte am offenen Markt gemeldet, und die Einreichung enthält keine weiteren wesentlichen Offenlegungen oder Änderungen. Die Transaktion erscheint routinemäßig und ist nicht an einen Handelsplan nach Regel 10b5-1 gebunden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Borenstein Hali

(Last) (First) (Middle)
3438 PEACHTREE ROAD NE
SUITE 1800

(Street)
ATLANTA GA 30326

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CARTERS INC [ CRI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/20/2025 A 14.8783(1) A $0 16,975.0112 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock credited to the Reporting Person as a result of a dividend payment with respect to the Company's common stock, in accordance with and to be settled pursuant to the terms of the Company's director deferred compensation program.
Remarks:
/s/Derek Swanson, Attorney-in-Fact 06/23/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CRI shares did director Hali Borenstein acquire on 06/20/2025?

The Form 4 states she was credited with 14.8783 shares of Carter's common stock.

What is Hali Borenstein’s total direct ownership after the reported transaction?

Following the credit, she directly owns 16,975.0112 CRI shares.

Was any cash paid for the shares reported in the Form 4?

No. The shares were credited at $0.00 per share as a dividend-equivalent under the director deferred-compensation plan.
Carters

NYSE:CRI

CRI Rankings

CRI Latest News

CRI Latest SEC Filings

CRI Stock Data

1.11B
35.11M
2.87%
121.85%
13.63%
Apparel Retail
Apparel & Other Finishd Prods of Fabrics & Similar Matl
Link
United States
ATLANTA